Ind-Swift Laboratories Limited
NSE:INDSWFTLAB.NS
117.51 (INR) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 12,808.999 | 12,073.1 | 10,387.336 | 8,913.445 | 7,796.431 | 7,566.025 | 7,654.828 | 6,974.17 | 6,532.491 | 6,604.523 | 9,650.825 | 11,360.93 | 14,091.745 | 10,485.252 | 7,852.887 | 5,901.962 | 4,577.807 | 3,502.429 |
| Cost of Revenue
| 8,675.782 | 6,555.84 | 6,107.243 | 5,302.514 | 4,733.338 | 4,677.291 | 4,738.675 | 4,491.168 | 4,028.579 | 4,623.495 | 8,084.154 | 9,586.059 | 11,209.283 | 8,162.13 | 6,080.491 | 4,254.778 | 3,327.289 | 2,549.02 |
| Gross Profit
| 4,133.217 | 5,517.26 | 4,280.093 | 3,610.931 | 3,063.093 | 2,888.734 | 2,916.153 | 2,483.002 | 2,503.912 | 1,981.028 | 1,566.671 | 1,774.871 | 2,882.462 | 2,323.122 | 1,772.396 | 1,647.184 | 1,250.518 | 953.409 |
| Gross Profit Ratio
| 0.323 | 0.457 | 0.412 | 0.405 | 0.393 | 0.382 | 0.381 | 0.356 | 0.383 | 0.3 | 0.162 | 0.156 | 0.205 | 0.222 | 0.226 | 0.279 | 0.273 | 0.272 |
| Reseach & Development Expenses
| 355.166 | 425.738 | 327.161 | 66.901 | 3.93 | 5.332 | 3.095 | 1.922 | 4.224 | 82.164 | 77.935 | 76.041 | 0 | 56.841 | 52.269 | 49.381 | 36.836 | 54.451 |
| General & Administrative Expenses
| 0 | 205.155 | 196.208 | 172.902 | 173.803 | 171.29 | 176.473 | 61.593 | 159.625 | 95.668 | 211.342 | 222.206 | 815.295 | 233.535 | 181.005 | 159.489 | 141.291 | 131.078 |
| Selling & Marketing Expenses
| 0 | 430.613 | 437.416 | 320.84 | 248.102 | 251.719 | 314.973 | 217.158 | 322.058 | 312.318 | 170.984 | 294.774 | 0 | 182.147 | 167.549 | 118.589 | 70.719 | 73.951 |
| SG&A
| 2,124.184 | 635.768 | 633.624 | 493.742 | 421.905 | 423.009 | 491.446 | 278.751 | 481.683 | 407.985 | 382.326 | 516.98 | 815.295 | 415.681 | 348.554 | 278.077 | 212.01 | 205.029 |
| Other Expenses
| 453.675 | 335 | 139.962 | 34.804 | -5.96 | 29.123 | 39.858 | 30.189 | 26.103 | 13.184 | 19.736 | 108.601 | 845.176 | 394.366 | 376.309 | 322.454 | 268.84 | 182.91 |
| Operating Expenses
| 2,124.184 | 3,798.907 | 3,355.987 | 2,501.499 | 2,331.833 | 2,347.908 | 2,298.021 | 2,138.397 | 2,169.942 | 1,761.705 | 1,546.284 | 1,568.486 | 1,167.644 | 866.888 | 777.132 | 649.913 | 517.686 | 442.39 |
| Operating Income
| 2,009.033 | 1,815.208 | 924.229 | 1,109.599 | 739.597 | 444.897 | 474.203 | -583.589 | -853.918 | -1,446.814 | -1,440.366 | -1,297.015 | 1,714.817 | 1,456.234 | 995.265 | 997.271 | 732.832 | 511.019 |
| Operating Income Ratio
| 0.157 | 0.15 | 0.089 | 0.124 | 0.095 | 0.059 | 0.062 | -0.084 | -0.131 | -0.219 | -0.149 | -0.114 | 0.122 | 0.139 | 0.127 | 0.169 | 0.16 | 0.146 |
| Total Other Income Expenses Net
| 3,808.539 | -952.339 | -798.904 | -929.514 | -937.309 | 51.871 | -114.902 | -898.009 | -1,161.77 | -1,652.953 | -1,441.018 | -1,394.799 | -849.35 | -593.756 | -491.051 | -497.662 | -340.141 | -265.572 |
| Income Before Tax
| 5,817.572 | 865.212 | 125.324 | 180.085 | -197.712 | 591.71 | 359.301 | -553.404 | -827.8 | -1,433.63 | -1,420.63 | -1,188.414 | 865.467 | 862.479 | 504.213 | 499.609 | 392.692 | 245.447 |
| Income Before Tax Ratio
| 0.454 | 0.072 | 0.012 | 0.02 | -0.025 | 0.078 | 0.047 | -0.079 | -0.127 | -0.217 | -0.147 | -0.105 | 0.061 | 0.082 | 0.064 | 0.085 | 0.086 | 0.07 |
| Income Tax Expense
| 1,603.055 | 386.853 | 146.814 | 211.557 | 14.171 | 207.305 | 140.105 | -161.794 | -240.936 | -240.009 | -200.509 | -8.766 | -917.749 | -32.142 | -59.648 | 95.692 | 78.478 | 63.059 |
| Net Income
| 4,209.616 | 475.966 | -21.49 | -31.472 | -211.883 | 384.404 | 219.197 | -391.609 | -586.879 | -1,193.621 | -1,220.121 | -1,179.648 | 891.608 | 894.621 | 563.861 | 403.917 | 314.214 | 182.388 |
| Net Income Ratio
| 0.329 | 0.039 | -0.002 | -0.004 | -0.027 | 0.051 | 0.029 | -0.056 | -0.09 | -0.181 | -0.126 | -0.104 | 0.063 | 0.085 | 0.072 | 0.068 | 0.069 | 0.052 |
| EPS
| 71.24 | 8.06 | -0.36 | -0.53 | -4.28 | 7.04 | 4.86 | -9.21 | -14.33 | -29.14 | -29.79 | -30.09 | 24.86 | 29.76 | 20.86 | 16.22 | 13.63 | 8.21 |
| EPS Diluted
| 71.24 | 8.06 | -0.36 | -0.53 | -4.28 | 7.04 | 4.86 | -9.2 | -14.33 | -29.14 | -29.79 | -29.84 | 23.98 | 27.57 | 20.19 | 15.31 | 13.43 | 8.12 |
| EBITDA
| 2,542.061 | 2,626.976 | 2,486.902 | 1,986.534 | 1,726.847 | 1,642.123 | 1,514.125 | 1,129.874 | 1,058.043 | 931.028 | 1,006.691 | 892.185 | 2,111.339 | 1,841.398 | 1,484.016 | 1,288.506 | 931.928 | 627.266 |
| EBITDA Ratio
| 0.198 | 0.218 | 0.239 | 0.223 | 0.221 | 0.217 | 0.198 | 0.162 | 0.162 | 0.141 | 0.104 | 0.079 | 0.15 | 0.176 | 0.189 | 0.218 | 0.204 | 0.179 |